Iodized oil in the treatment of hepatocellular carcinoma
- 1 November 1994
- journal article
- review article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 81 (11) , 1563-1571
- https://doi.org/10.1002/bjs.1800811105
Abstract
When injected into the hepatic artery the contrast agent Lipiodol (iodized poppy seed oil) is selectively retained by hepatocellular carcinoma (HCC) for a prolonged period of time. Liver computed tomography (CT) performed after Lipiodol angiography is more sensitive than ordinary CT at imaging HCC. Arterial administration of cytotoxic drugs and radioisotopes conjugated to Lipiodol has been shown to be reasonably safe in patients with irresectable HCC. These therapies, often combined with embolization, provide effective palliation, better tumour response and improved survival compared with other available treatments. Their use as a preoperative adjunct to surgical resection of HCC is controversial.Keywords
This publication has 85 references indexed in Scilit:
- Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients.American Journal of Roentgenology, 1993
- Targeting chemotherapy for hepatoma: Arterial administration of anticancer drugs dissolved in lipiodolEuropean Journal Of Cancer, 1992
- Internal radiation therapy for hepatocellular carcinoma. Results of a french multicenter phase II trial of transarterial injection of iodine 131-labeled lipiodolCancer, 1992
- Selective internal radiation therapy: Distribution of radiation in the liverEuropean Journal of Cancer and Clinical Oncology, 1989
- Hepatocellular carcinoma. A retrospective analysis of treatments to manage disease confined to the liverCancer, 1988
- Distribution of different sized microspheres in experimental hepatic tumoursEuropean Journal of Cancer and Clinical Oncology, 1987
- Therapeutic use of 90Y microspheresInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1987
- Primary hepatocellular carcinoma localised by a radiolabelled monoclonal antibodyJournal of Hepatology, 1986
- Mitozantrone as single agent therapy in hepatocellular carcinomaJournal of Hepatology, 1985
- Experimental studies on the uptake and retention of labelled proteins in a rat tumourPublished by Elsevier ,1973